Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres, 98166 Messina, Italy.
Istituto Oncologico del Mediterraneo, Via Penninazzo 7, 95029 Viagrande, Italy.
Molecules. 2021 Jun 29;26(13):3963. doi: 10.3390/molecules26133963.
Since cancer is a multifactorial disease with a high mortality rate, the study of new therapeutic strategies is one of the main objectives in modern research. Numerous chemotherapeutic agents, although widely used, have the disadvantage of being not very soluble in water or selective towards cancerous cells, with consequent side effects. Therefore, in recent years, a greater interest has emerged in innovative drug delivery systems (DDSs) such as calixarene, a third-generation supramolecular compound. Calixarene and its water-soluble derivatives show good biocompatibility and have low cytotoxicity. Thanks to their chemical-physical characteristics, calixarenes can be easily functionalized, and by itself can encapsulate host molecules forming nanostructures capable of releasing drugs in a controlled way. The encapsulation of anticancer drugs in a calixarene derivate improves their bioavailability and efficacy. Thus, the use of calixarenes as carriers of anticancer drugs could reduce their side effects and increase their affinity towards the target. This review summarizes the numerous research advances regarding the development of calixarene nanoparticles capable of encapsulating various anticancer drugs.
由于癌症是一种具有高死亡率的多因素疾病,因此研究新的治疗策略是现代研究的主要目标之一。尽管许多化疗药物被广泛使用,但它们在水中的溶解度不高或对癌细胞的选择性不高,因此会产生相应的副作用。因此,近年来,人们对创新药物输送系统(DDS)越来越感兴趣,例如杯芳烃,这是一种第三代超分子化合物。杯芳烃及其水溶性衍生物具有良好的生物相容性和低细胞毒性。由于其理化特性,杯芳烃可以很容易地进行功能化,并且本身可以包封主体分子,形成能够以受控方式释放药物的纳米结构。将抗癌药物封装在杯芳烃衍生物中可以提高其生物利用度和功效。因此,将杯芳烃用作抗癌药物的载体可以降低其副作用并提高其对靶标的亲和力。本文综述了关于能够封装各种抗癌药物的杯芳烃纳米粒子的众多研究进展。